Publications by authors named "Philippe Chollet"

Claim this Profile
C
Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second-line docetaxel: A randomized trial.
Passildas Jahanmohan Judith, Bernadach Maureen, Pouget Mélanie, Kwiatkowski Fabrice, Vanpraagh-Doreau Isabelle, Chollet Philippe

Health Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial.
Pasquale F Innominato, Abdoulaye Karaboué, Christian Focan, Philippe Chollet, Sylvie Giacchetti

Int J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.
Judith Passildas-Jahanmohan, Jean-Christophe Eymard, Mélanie Pouget, Fabrice Kwiatkowski, Isabelle Van Praagh, Philippe Chollet

Cancer Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program.
Laure Vacher, Emilie Thivat, Camille Poirier, Marie-Ange Mouret-Reynier, Philippe Chollet

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.
Pasquale F Innominato, Annabelle Ballesta, Qi Huang, Christian Focan, Philippe Chollet

Cancer Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Hakim Mahammedi, Eloise Planchat, Mélanie Pouget, Xavier Durando, Hervé Curé, Philippe Chollet

Oncology· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
Mélanie Pouget, Catherine Abrial, Eloise Planchat, Isabelle Van Praagh, Marie Arbre, Philippe Chollet

Oncology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Qian Wang-Lopez, Nassera Chalabi, Catherine Abrial, Nina Radosevic-Robin, Xavier Durando, Philippe Chollet

Crit Rev Oncol Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy.
Xavier Durando, Florence Dalenc, Catherine Abrial, Marie-Ange Mouret-Reynier, Pauline Herviou, Philippe Chollet

Oncology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.
Qian Wang-Lopez, Marie-Ange Mouret-Reynier, Aude-Marie Savoye, Catherine Abrial, Fabrice Kwiatkowski, Philippe Chollet

Oncologist· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drimane-Type Sesquiterpene Coumarins from Ferula gummosa Fruits Enhance Doxorubicin Uptake in Doxorubicin-Resistant Human Breast Cancer Cell Line.
Mehrdad Iranshahi, Chantal Barthomeuf, Mathilde Bayet-Robert, Philippe Chollet, Davood Davoodi

J Tradit Complement Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term significance (15 years) of pathological complete response after dose-dense neoadjuvant chemotherapy in breast cancer.
Qian Wang-Lopez, Catherine Abrial, Eloïse Planchat, Marie-Ange Mouret-Reynier, Hervé Cure, Philippe Chollet

Breast J· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Javier Cortes, Joyce O'Shaughnessy, David Loesch, Joanne L Blum, Linda T Vahdat, Philippe Chollet

Lancet· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.
Emilie Thivat, Sophie Thérondel, Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Philippe Chollet

BMC Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.
Xavier Durando, Marie-Chantal Farges, Emmanuel Buc, Catherine Abrial, Caroline Petorin-Lesens, Philippe Chollet

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses.
Mathilde Bayet-Robert, Daniel Morvan, Philippe Chollet, Chantal Barthomeuf

Breast Cancer Res Treat· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.
Aurelie Cabrespine-Faugeras, Mathilde Bayet-Robert, Jacques-Olivier Bay, Philippe Chollet, Chantal Barthomeuf

Nutr Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Olivier Gilliot, Xavier Durando, Catherine Abrial, Aurélie Bellière, Pierre Gimbergues, Philippe Chollet

Cancer Invest· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.
Mathilde Bayet-Robert, Fabrice Kwiatkowski, Marianne Leheurteur, Françoise Gachon, Eloïse Planchat, Philippe Chollet

Cancer Biol Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer.
Jean-Marc Nabholtz, Marie-Ange Mouret-Reynier, Xavier Durando, Isabelle Van Praag, Béatrice Nayl, Philippe Chollet

Indian J Surg Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma.
Emilie Thivat, Marie-Chantal Farges, Franck Bacin, Michel D'Incan, Marie-Ange Mouret-Reynier, Philippe Chollet

Anticancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A Working Group analysis.
Rémy Largillier, Alexia Savignoni, Joseph Gligorov, Philippe Chollet, Marie-Noëlle Guilhaume

Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.
Catherine Abrial, Xavier Durando, Marie-Ange Mouret-Reynier, Emilie Thivat, Mathilde Bayet-Robert, Philippe Chollet

Int J Gen Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer.
Jean-Marc Nabholtz, Marie-Ange Mouret-Reynier, Xavier Durando, Isabelle Van Praagh, Sana Al-Sukhun, Philippe Chollet

Expert Opin Pharmacother· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer.
Pasquale F Innominato, Christian Focan, Thierry Gorlia, Thierry Moreau, Carlo Garufi, Philippe Chollet

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis